STOCK TITAN

Sotera Health (SHC) amends First Lien Credit Agreement and reprices term loans

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Sotera Health Company entered into Amendment No. 7 to its First Lien Credit Agreement, under which 2026 Refinancing Term Lenders will provide term loans to Sotera Health Holdings, LLC in an aggregate principal amount of $1,415,914,725.62. The amendment mainly reprices existing debt by reducing the interest rate spread by 0.25% across term loans under the facility.

The repriced term loans will bear interest at Adjusted Term SOFR plus 2.25%, with an option to elect Alternate Base Rate plus 1.25% or Adjusted Daily Simple SOFR plus 2.25%. The loans carry a 1.00% soft call premium for certain repricing transactions within six months of the amendment’s effective date, amortize at 1.00% per year, and mature on May 30, 2031.

Positive

  • None.

Negative

  • None.
Item 1.01 Entry into a Material Definitive Agreement Business
The company signed a significant contract such as a merger agreement, credit facility, or major partnership.
Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement Financial
The company incurred a new significant debt or off-balance-sheet obligation.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Repriced term loans principal $1,415,914,725.62 Aggregate principal amount of Repriced Term Loans to SHH
Spread reduction 0.25% Interest rate spread reduction across term loans
SOFR margin 2.25% Margin over Adjusted Term SOFR on repriced term loans
Alternate Base Rate margin 1.25% Interest margin if Alternate Base Rate is elected
Daily Simple SOFR margin 2.25% Interest margin if Adjusted Daily Simple SOFR is elected
Soft call premium 1.00% Premium on certain repricing transactions within six months
Amortization rate 1.00% per annum Annual amortization of Repriced Term Loans
Loan maturity May 30, 2031 Maturity date of Repriced Term Loans
First Lien Credit Agreement financial
"Amendment No. 7 to the First Lien Credit Agreement dated as of December 13, 2019"
A first lien credit agreement is a loan contract that gives the lender the top legal claim on a borrower's specific assets if the borrower defaults, like a mortgage that gets paid before others when a house is sold. It matters to investors because holders of first-lien debt are paid before other creditors and shareholders in a distress situation, which lowers their risk and can affect a company's borrowing costs, financial flexibility, and the value of other securities.
Adjusted Term SOFR financial
"applicable interest rate margin equal to Adjusted Term SOFR plus 2.25%"
Adjusted term SOFR is a forward‑looking interest benchmark based on short‑term overnight Treasury repo rates, with a small extra amount added to reflect differences from legacy rates. Think of it as a quoted price that has been nudged to make payments comparable to older benchmarks; it matters to investors because it directly influences borrowing costs, bond yields and cash‑flow forecasts, affecting valuations and hedging outcomes.
Alternate Base Rate financial
"optionality for the Company to elect Alternate Base Rate plus 1.25%"
Adjusted Daily Simple SOFR financial
"or Adjusted Daily Simple SOFR plus 2.25% (each as defined in the Credit Agreement)"
soft call premium financial
"subject to a “soft call” premium of 1.00% for certain repricing transactions"
amortize financial
"The Repriced Term Loans amortize at a rate of 1.00% per annum"
To amortize means to spread the repayment of a debt or the recognition of a cost over a series of scheduled payments or accounting periods. For investors, amortization shows how much of a loan payment reduces principal versus interest or how a one-time expense is gradually charged to profits, helping reveal a company’s true cash obligations and ongoing earnings power—think of paying off a big purchase with a fixed monthly plan so the cost isn’t all felt at once.
Sotera Health Co false 0001822479 0001822479 2026-05-20 2026-05-20
 
 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported): May 20, 2026

 

 

SOTERA HEALTH COMPANY

(Exact Name of Registrant as Specified in Charter)

 

 

 

Delaware   001-39729   47-3531161
(State or Other Jurisdiction
of Incorporation)
 

(Commission

File Number)

  (IRS Employer
Identification No.)

9100 South Hills Blvd, Suite 300

Broadview Heights, Ohio 44147

(Address of Principal Executive Offices) (Zip Code)

(440) 262-1410

(Registrant’s telephone number, including area code)

Not Applicable

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of Each Class

 

Trading
Symbol

 

Name of Exchange

on which registered

Common stock, $0.01 par value per share   SHC   The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR 230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR 240.12b-2).

Emerging growth company 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 
 


Item 1.01

Entry into a Material Definitive Agreement.

Credit Agreement

On May 20, 2026, Sotera Health Company (the “Company”), Sotera Health Holdings, LLC (“SHH”), certain subsidiaries of the Company, each 2026 Refinancing Term Lender (the “Refinancing Lenders”) and JPMorgan Chase Bank, N.A., as first lien Administrative Agent (the “Administrative Agent”) entered into Amendment No. 7 (the “Amendment”) to the First Lien Credit Agreement dated as of December 13, 2019, by and among the Company, SHH, the Administrative Agent and the lenders and issuing banks party thereto (the “Credit Agreement”).

Among other changes, the Amendment provides that the Refinancing Lenders will provide term loans (the “Repriced Term Loans”) to SHH in an aggregate principal amount of $1,415,914,725.62.

The Amendment reduces the interest rate spread by 0.25% across term loans under the facility. The Repriced Term Loans shall have an applicable interest rate margin equal to Adjusted Term SOFR (as defined in the Credit Agreement) plus 2.25%, with a 0.00% floor (with optionality for the Company to elect Alternate Base Rate plus 1.25% or Adjusted Daily Simple SOFR plus 2.25% (each as defined in the Credit Agreement)).

The Repriced Term Loans are also subject to a “soft call” premium of 1.00% for certain repricing transactions with respect to the Repriced Term Loans that occur within the six-month period after the effective date of the Amendment. The Repriced Term Loans amortize at a rate of 1.00% per annum and mature on May 30, 2031.

The foregoing description of certain provisions of the Amendment and the underlying Credit Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Credit Agreement and the Amendment, a copy of which is attached hereto as Exhibit 10.1 and incorporated herein by reference.

 

Item 2.03

Creation of a Direct Financial Obligation or an obligation under an Off-Balance Sheet Arrangement of a Registrant.

The disclosure set forth under Item 1.01 above is incorporated herein by reference.

 

Item 9.01

Financial Statements and Exhibits.

(d) Exhibits:

 

Exhibit

No.

   Description
10.1    Amendment No. 7, dated as of May 20, 2026, to the First Lien Credit Agreement dated as of December 13, 2019 by and among Sotera Health Company, Sotera Health Holdings, LLC, certain subsidiaries of Sotera Health Company, JPMorgan Chase Bank, N.A., as First Lien Administrative Agent, and the 2026 Refinancing Term Lenders party thereto.
104    Cover Page Interactive Data File (embedded within the Inline XBRL document).


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

   

Sotera Health Company

   (Registrant)

Date: May 20, 2026     By:  

/s/ Jonathan M. Lyons

      Jonathan M. Lyons
      Senior Vice President and Chief Financial Officer

FAQ

What did Sotera Health Company (SHC) change in its credit agreement?

Sotera Health Company entered Amendment No. 7 to its First Lien Credit Agreement, repricing term loans and adjusting interest margins, soft call provisions, amortization rate, and maturity for its existing term loan facility.

How large are the repriced term loans in Sotera Health’s amendment?

The repriced term loans total an aggregate principal amount of $1,415,914,725.62. These loans are provided to Sotera Health Holdings, LLC by the 2026 Refinancing Term Lenders under the amended First Lien Credit Agreement.

How did Sotera Health adjust interest rates on its term loans?

The amendment reduces the interest rate spread by 0.25% across term loans. The repriced loans now bear interest at Adjusted Term SOFR plus 2.25%, with alternatives of Alternate Base Rate plus 1.25% or Adjusted Daily Simple SOFR plus 2.25%.

When do Sotera Health’s repriced term loans mature?

The repriced term loans under the amended First Lien Credit Agreement mature on May 30, 2031. They also amortize at a rate of 1.00% per annum over the life of the facility.

What is the soft call premium in Sotera Health’s amended term loans?

The repriced term loans include a 1.00% soft call premium. This applies to certain repricing transactions involving these loans that occur within six months after the effective date of Amendment No. 7.

Which lenders and agent are involved in Sotera Health’s amended facility?

The repriced term loans are provided by 2026 Refinancing Term Lenders, with JPMorgan Chase Bank, N.A. serving as first lien Administrative Agent under the amended First Lien Credit Agreement.

Filing Exhibits & Attachments

4 documents